Tirodril

Tirodril may be available in the countries listed below.

Ingredient matches for Tirodril

Thiamazole

Thiamazole is reported as an ingredient of Tirodril in the following countries:

• Spain

International Drug Name Search

Clavulin

Clavulin may be available in the countries listed below.

Ingredient matches for Clavulin

Amoxicillin

Amoxicillin is reported as an ingredient of Clavulin in the following countries:

• Australia

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Clavulin in the following countries:

• Australia


• Brazil


• Canada


• Colombia


• Italy


• Mexico

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Clavulin in the following countries:

• Australia


• Brazil


• Canada


• Colombia


• Italy


• Mexico

International Drug Name Search

Refacto

Generic Name: antihemophilic factor (Intravenous route)

an-tee-hee-moe-FIL-ik FAK-tor

Commonly used brand name(s)

In the U.S.

• Advate


• Helixate FS


• Hemofil-M


• Hyate:C


• Koate DVI


• Kogenate FS


• Kogenate FS w/BIO-SET


• Monarc-M


• Monoclate-P


• Recombinate


• Refacto


• Xyntha

Available Dosage Forms:

• Powder for Solution

Therapeutic Class: Antihemophilic Agent

Uses For Refacto

Antihemophilic factor (AHF) injection is used to treat serious bleeding episodes in patients with a bleeding problem called hemophilia A. The bleeding episode may be related to an injury (trauma) or a surgical procedure. AHF is a protein that is produced naturally in the body. It helps the blood form clots to stop bleeding and prevents bleeding problems from happening as often.

Hemophilia A, also called classical hemophilia, is a condition where the body does not make enough AHF. If you do not have enough AHF and you become injured, your blood will not form clots properly. You might bleed into and damage your muscles and joints. AHF injection is given to increase the levels of AHF in the blood.

There are several different types of AHF. They are made from human blood or artificially by a man-made process (recombinant). AHF made from human blood has been treated and is not likely to contain harmful viruses, such as hepatitis B, hepatitis C, or human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS). The man-made AHF products do not contain these viruses.

This medicine is available only with your doctor's prescription.

Before Using Refacto

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of antihemophilic factor injection in children.

No information is available on the relationship of age to the effects of Hemofil® M in the pediatric population. Safety and efficacy have not been established.

Geriatric

Although appropriate studies on the relationship of age to the effects of Advate® have not been performed in the geriatric population, no geriatric-specific problems have been documented to date. However, elderly patients are more likely to have age-related medical problems, which may require caution and an adjustment in the dose for patients receiving Advate®.

No information is available on the relationship of age to the effects of antihemophilic factor injection in geriatric patients.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Allergy to hamster or mouse proteins, history of or


• von Willebrand disease—Should not be used in patients with these conditions.

Proper Use of antihemophilic factor

This section provides information on the proper use of a number of products that contain antihemophilic factor. It may not be specific to Refacto. Please read with care.

A doctor or other trained health professional will give you or your child this medicine in a hospital or clinic setting. This medicine is given through a needle placed in one of your veins.

This medicine may also be given at home to patients who do not need to be in a hospital or clinic. If you or your child are using this medicine at home, your doctor will teach you how to prepare and inject the medicine. Make sure you understand all of the instructions before giving yourself an injection. Your dose may change based on where you are bleeding. Do not use more medicine or use it more often than your doctor tells you to.

Use only the brand of this medicine that your doctor prescribed. Not all brands are prepared in the same way and the dose may be different.

Every package of medicine comes with a patient information leaflet. Read and follow the instructions carefully. Ask your doctor if you have any questions.

To prepare the medicine using 2 bottles (vials) or containers:

• Take the bottles of powder medicine and liquid (diluent) out of the refrigerator and warm them to room temperature.


• Wipe the rubber surface of the bottles with an alcohol swab and allow them to dry.


• Follow the specific directions for your brand of medicine when you prepare the injection.


• Add the liquid to the powder using the special transfer needle or transfer device that comes with the package.


• When injecting the liquid into the dry medicine, aim the stream of liquid against the wall of the container of dry medicine to prevent foaming.


• Swirl the bottle gently to dissolve the medicine. Do not shake the bottle. Shaking will create foam in the mixture.


• Check the mixture to make sure it is clear. Do not use the medicine if you can see anything solid in the mixture or if the mixture is cloudy.


• Use a plastic disposable syringe to remove the mixture from the bottle. Use a special filter needle if your brand of medicine provides one.


• Give the injection as directed by your doctor.


• If you are using more than one bottle of medicine for your dose, prepare the second bottle the same way. Add the mixture from the second bottle to the same syringe.

To prepare the medicine using a prefilled dual-chamber syringe (Xyntha®):

• Take the prefilled dual-chamber syringe out of the refrigerator and warm it to room temperature.


• The dual-chamber syringe has the powder medicine in one part and the liquid (diluent) in the second part of the syringe.


• Attach the plunger rod to the syringe according to the directions. Keep the syringe pointed up to prevent leaking of the liquid.


• Remove the white seal and the grey rubber tip cap. Put the blue vented cap on the syringe. Do not touch the open ends of the syringe and the blue cap.


• Slowly push the plunger until the 2 stoppers inside the syringe are together. This will push all of the liquid into the chamber with the powder medicine.


• Keep the syringe pointed up and gently swirl the syringe to mix the liquid and powder.


• Check the mixture to make sure it is clear. Do not use the medicine if you can see anything solid in the mixture or if the mixture is cloudy.


• Keep the syringe pointed up and push the plunger until most of the air is removed.


• A special infusion set comes with the package. Remove the blue cap and attach the infusion set to the syringe.


• Give the injection as directed by your doctor.


• If you are using more than one syringe of medicine for your dose, prepare the second dual-chamber syringe the same way. The mixture from each syringe will be combined together in a separate syringe before your injection. Your doctor will show you how to do this.

Use the mixture within 3 hours after it is prepared. It must not be stored and used later. Do not put the mixture in the refrigerator.

Do not reuse syringes and needles. Put used syringes and needles in a puncture-resistant disposable container, or dispose of them as directed by your doctor.

Talk to your doctor before traveling. You should plan to bring enough medicine for your treatment when traveling.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For injection dosage form (injection):
  
  • For bleeding episodes in patients with hemophilia A:
    
    • Adults and teenagers—Dose is based on body weight and the type of bleeding episode. The dose must be determined by your doctor.
    
    
    • Children—Dose is based on body weight and the type of bleeding episode. The dose must be determined by your child's doctor.
    
    
  
  

Missed Dose

Call your doctor or pharmacist for instructions.

Storage

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

The AHF products should be stored in the original container in the refrigerator. Do not let the packages freeze. They can also be kept at room temperature for short periods of time, such as 3 to 6 months. Store the medicine as directed by your doctor or by the manufacturer of the brand you are using. Protect the container from heat and direct light.

If you move the medicine from the refrigerator to room temperature, write the date you take it from the refrigerator on the container. The length of time the medicine can remain at room temperature will depend on the brand you use. If you have already stored the medicine at room temperature, do not return it to the refrigerator. If you do not use the medicine within the time recommended by the manufacturer, you must destroy the medicine.

Precautions While Using Refacto

It is very important that your doctor check you or your child closely while you are receiving this medicine to make sure it is working properly. Blood tests may be needed.

This medicine may cause serious types of allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Stop using this medicine and check with your doctor right away if you or your child have a rash; itching; hoarseness; trouble breathing; trouble swallowing; lightheadedness or dizziness; or any swelling of your hands, face, or mouth after you receive this medicine.

It is recommended that you carry an identification (ID) card or letter stating that you have hemophilia A and the type of medicine you are using. If you have any questions about what kind of identification to carry, check with your doctor.

Check with your doctor right away if you have any symptoms of parvovirus infection: fever, chills, drowsiness, runny nose, and followed by a rash or joint pain.

Check with your doctor right away if you have pain or tenderness in the upper stomach; pale stools; dark urine; loss of appetite; nausea; unusual tiredness or weakness; or yellow eyes or skin. These could be symptoms of a serious liver problem.

This medicine is made from donated human blood. Some human blood products have transmitted certain viruses to people who have received them. The risk of getting a virus from medicines made of human blood has been greatly reduced in recent years. This is the result of required testing of human donors for certain viruses, and testing during manufacture of these medicines. Although the risk is low, talk with your doctor if you have any concerns.

The stopper of the bottle (vial) contains dry natural rubber (a derivative of latex), which may cause allergic reactions in people who are sensitive to latex. Tell your doctor if you have a latex allergy before you start using this medicine.

Refacto Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

More common

• Fever

Less common or rare

• Changes in facial skin color


• chills


• fast or irregular breathing


• nausea


• puffiness or swelling of the eyelids or around the eyes


• sensation of burning, warmth, heat, numbness, tightness, or tingling


• shortness of breath


• skin rash, hives, or itching


• tightness in the chest


• troubled breathing


• unusual tiredness or weakness


• wheezing

Incidence not known

• Bluish color of the fingernails, lips, skin, palms, or nail beds


• blurred vision


• chest pain or discomfort


• confusion


• cough


• deep or fast breathing with dizziness


• difficult or labored breathing


• difficulty with swallowing


• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position


• fast, pounding, or irregular heartbeat or pulse


• noisy breathing


• numbness of the feet, hands, and around the mouth


• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue


• slow or irregular heartbeat


• sweating


• swelling of the face, throat, or tongue


• unusual tiredness or weakness

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Headache

Less common

• Burning, stinging, or swelling at the place of injection


• diarrhea


• dizziness or lightheadedness


• dry mouth or bad taste in the mouth


• lack or loss of strength


• nosebleed


• redness of the face


• vomiting

Rare

• Change in taste


• loss of taste

Incidence not known

• Abdominal or stomach pain


• feeling of warmth


• increased sweating


• irritability


• muscle or bone pain


• redness of the eye


• redness of the face, neck, arms, and occasionally, upper chest


• redness of the skin


• trouble seeing

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Refacto side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Refacto resources

• Refacto Side Effects (in more detail)
• Refacto Use in Pregnancy & Breastfeeding
• Refacto Support Group
• 0 Reviews for Refacto - Add your own review/rating

• Antihemophilic Factor Professional Patient Advice (Wolters Kluwer)


• Advate MedFacts Consumer Leaflet (Wolters Kluwer)


• Advate Prescribing Information (FDA)


• Advate Consumer Overview


• Antihemophilic Factor (Human) Monograph (AHFS DI)


• Antihemophilic Factor (Recombinant) Monograph (AHFS DI)


• Helixate FS Prescribing Information (FDA)


• Kogenate Consumer Overview


• Kogenate FS Prescribing Information (FDA)


• Kogenate FS MedFacts Consumer Leaflet (Wolters Kluwer)


• Monoclate-P Prescribing Information (FDA)


• Recombinate Prescribing Information (FDA)


• Xyntha Prescribing Information (FDA)


• Xyntha MedFacts Consumer Leaflet (Wolters Kluwer)


• Xyntha Consumer Overview

Compare Refacto with other medications

• Hemophilia A

Ezol

In the US, Ezol is a member of the drug class analgesic combinations and is used to treat Headache.

Ingredient matches for Ezol

Omeprazole

Omeprazole is reported as an ingredient of Ezol in the following countries:

• India

International Drug Name Search

Nitagon

Nitagon may be available in the countries listed below.

Ingredient matches for Nitagon

Permethrin

Permethrin is reported as an ingredient of Nitagon in the following countries:

• South Africa

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Nitagon in the following countries:

• South Africa

International Drug Name Search

Cipril

Cipril may be available in the countries listed below.

Ingredient matches for Cipril

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Cipril in the following countries:

• India

International Drug Name Search

Peganone

Peganone is a brand name of ethotoin, approved by the FDA in the following formulation(s):

PEGANONE (ethotoin - tablet; oral)

• 
  Manufacturer: LUNDBECK INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 250MG ^[RLD]

Has a generic version of Peganone been approved?

No. There is currently no therapeutically equivalent version of Peganone available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Peganone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Peganone.

See also...

• Peganone Consumer Information (Wolters Kluwer)
• Peganone Consumer Information (Cerner Multum)
• Peganone Advanced Consumer Information (Micromedex)
• Ethotoin Consumer Information (Wolters Kluwer)
• Ethotoin Consumer Information (Cerner Multum)
• Ethotoin Advanced Consumer Information (Micromedex)

Deferoxamine

Pronunciation: de-fer-OX-a-meen
Generic Name: Deferoxamine
Brand Name: Desferal

Deferoxamine is used for:

Treating acute iron poisoning and chronic iron overload caused by anemias that require frequent blood transfusions.

Deferoxamine is an iron-chelating agent. It works by binding to excess iron in the blood so that it can be removed by the kidneys and bowels.

Do NOT use Deferoxamine if:

• you are allergic to any ingredient in Deferoxamine


• you have severe kidney problems or you are unable to urinate

Contact your doctor or health care provider right away if any of these apply to you.

Before using Deferoxamine:

Some medical conditions may interact with Deferoxamine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have brain or kidney disease, heart failure, a certain blood disorder (thalassemia), or low blood ferritin levels


• if you have a certain disease that prevents your body from breaking down iron (hemochromatosis)


• if you take vitamin C

Some MEDICINES MAY INTERACT with Deferoxamine. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Prochlorperazine because loss of consciousness may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Deferoxamine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Deferoxamine:

Use Deferoxamine as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Deferoxamine is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Deferoxamine at home, a health care provider will teach you how to use it. Be sure you understand how to use Deferoxamine. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.


• Do not use Deferoxamine if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.


• If you miss a dose of Deferoxamine, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Deferoxamine.

Important safety information:

• Deferoxamine may cause dizziness or changes in vision or hearing. These effects may be worse if you take it with alcohol or certain medicines. Use Deferoxamine with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not take large doses of vitamin C without first checking with your doctor.


• Deferoxamine may turn your urine a reddish color. This is normal and not a cause for concern.


• Certain infections (eg, Yersinia infections, mucormycosis) have rarely occurred in patients who take Deferoxamine. Seek immediate medical attention if you experience symptoms of infection (eg, chills, cough, diarrhea, fever, shortness of breath, sore throat, stomach pain, weakness).


• Tell your doctor or dentist that you take Deferoxamine before you receive any medical or dental care, emergency care, or surgery.


• Deferoxamine may interfere with certain lab imaging tests. Be sure your doctor and lab personnel know you are using Deferoxamine. You may need to stop Deferoxamine before you have certain types of imaging tests. Check with your doctor if you have questions.


• Lab tests, including eye exams, hearing, and kidney function, may be performed while you use Deferoxamine. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Deferoxamine with caution in the ELDERLY; they may be more sensitive to its effects, especially hearing loss or vision problems.


• Deferoxamine may affect weight and growth rate in CHILDREN in some cases. The weight and growth of CHILDREN receiving Deferoxamine should be monitored every 3 months.


• Use Deferoxamine with extreme caution in CHILDREN younger than 3 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Deferoxamine while you are pregnant. It is not known if Deferoxamine is found in breast milk. If you are or will be breast-feeding while you use Deferoxamine, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Deferoxamine:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; dizziness; headache; leg cramps; nausea; stomach upset; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bluish skin or nails; change in the amount of urine produced; cough; difficult or painful urination; fainting; fast heartbeat; fever, chills, or sore throat; flushing of the skin; hearing changes (eg, loss of hearing); muscle or joint pain; muscle spasms; numbness or tingling of the face, hands, feet, or skin; pain, burning, swelling, blistering, or redness at the injection site; ringing in the ears; seizures; severe or persistent dizziness; shortness of breath; swelling of the hands, ankles, or feet; symptoms of liver problems (eg, dark urine, pale stools, loss of appetite, severe stomach pain, unusual tiredness, yellowing of the eyes or skin); unusual bruising or bleeding; vision changes (eg, blurred vision, night blindness).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Deferoxamine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include agitation; change in the amount of urine produced; coma; fast or slow heartbeat; paleness; severe or persistent dizziness, drowsiness, headache, nausea, or vomiting; trouble speaking; vision changes.

Proper storage of Deferoxamine:

Deferoxamine is usually handled and stored by a health care provider. If you are using Deferoxamine at home, store Deferoxamine as directed by your pharmacist or health care provider. Keep Deferoxamine out of the reach of children and away from pets.

General information:

• If you have any questions about Deferoxamine, please talk with your doctor, pharmacist, or other health care provider.


• Deferoxamine is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Deferoxamine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Deferoxamine resources

• Deferoxamine Side Effects (in more detail)
• Deferoxamine Use in Pregnancy & Breastfeeding
• Deferoxamine Drug Interactions
• Deferoxamine Support Group
• 0 Reviews for Deferoxamine - Add your own review/rating

• Deferoxamine Prescribing Information (FDA)


• deferoxamine Injection Advanced Consumer (Micromedex) - Includes Dosage Information


• deferoxamine Concise Consumer Information (Cerner Multum)


• Deferoxamine Mesylate Monograph (AHFS DI)


• Desferal Prescribing Information (FDA)

Compare Deferoxamine with other medications

• Iron Poisoning, Acute
• Iron Poisoning, Chronic

Stopangin

Stopangin may be available in the countries listed below.

Ingredient matches for Stopangin

Hexetidine

Hexetidine is reported as an ingredient of Stopangin in the following countries:

• Czech Republic


• Georgia


• Latvia


• Slovakia

International Drug Name Search

Pregnenolone

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000145-13-1

Chemical Formula

C21-H32-O2

Molecular Weight

316

Therapeutic Category

Adrenal cortex hormone

Chemical Name

Pregn-5-en-20-one, 3-hydroxy-, (3ß)-

Foreign Names

• Pregnenolonum (Latin)
• Pregnenolon (German)
• Pregnénolone (French)
• Pregnenolona (Spanish)

Generic Names

• Pregnenolone (OS: BAN)
• Pregnénolone (OS: DCF)
• Skinostelon (IS)

Brand Name

• Metharmone F (Pregnenolone and Androstenedione)
  Nippon Zoki Seiykau, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Citodon minor

Citodon minor may be available in the countries listed below.

Ingredient matches for Citodon minor

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Citodon minor in the following countries:

• Sweden

Paracetamol

Paracetamol is reported as an ingredient of Citodon minor in the following countries:

• Sweden

International Drug Name Search

Tirofiban Hydrochloride

Tirofiban Hydrochloride may be available in the countries listed below.

Ingredient matches for Tirofiban Hydrochloride

Tirofiban

Tirofiban Hydrochloride (BANM, USAN) is known as Tirofiban in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Lyzyme

Lyzyme may be available in the countries listed below.

Ingredient matches for Lyzyme

Lysozyme

Lysozyme hydrochloride (a derivative of Lysozyme) is reported as an ingredient of Lyzyme in the following countries:

• Japan


• Singapore

International Drug Name Search

Flucloxacillina K24

Flucloxacillina K24 may be available in the countries listed below.

Ingredient matches for Flucloxacillina K24

Flucloxacillin

Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Flucloxacillina K24 in the following countries:

• Italy

International Drug Name Search